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Over the past two decades the “one drug – one target –
one disease” concept became the prevalent paradigm in
drug discovery. The main idea of this approach is the
identification of a single protein target whose inhibition
leads to a successful treatment of the examined disease.
The predominant assumption is that highly selective
ligands would avoid unwanted side effects caused by
binding to secondary non-therapeutic targets.
In recent years the results of post-genomic and net-
work biology showed that proteins rarely act in isolated
systems but rather as a part of a highly connected net-
work [1]. In addition this connectivity leads to more
robust systems that cannot be interfered by the inhibi-
tion of a single target of that network and consequently
might not lead to the desired therapeutic effect [2].
Furthermore studies prove that robust systems are
rather affected by weak inhibitions of several parts than
b yac o m p l e t ei n h i b i t i o no fasingle selected element of
that system [3].
Therefore there is an increasing interest in developing
drugs that take effect on multiple targets simultaneously
but is concurrently a great challenge for medicinal che-
mists. There has to be a sufficient activity on each target
as well as an adequate pharmacokinetic profile [4]. Early
design strategies tried to link the pharmacophors of
known inhibitors, however these methods often lead to
high molecular weight and low ligand efficacy.
We present a new rational approach based on a retro-
synthetic combinatorial analysis procedure [5] on
approved ligands of multiple targets. These RECAP frag-
ments are used to design a large combinatorial library
containing molecules featuring chemical properties of
each ligand class. The molecules are further validated by
machine learning models, like random forests and self-
organizing maps, regarding their activity on the targets
of interest.
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